RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Liver Reperfusion Injury
Accession: DOID:9002159
browse the term
Definition: Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the liver, including swelling; hemorrhage; necrosis; and damage from free radicals.
Synonyms: exact_synonym: Hepatic Ischemia-Reperfusion Injury; Hepatic Reperfusion Injury; Liver Ischemia-Reperfusion Injury
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
IDA
RGD
PMID:23762489
RGD:8695935
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
treatment
IEP ISO
mRNA,protein:increased expression:liver,plasma:
RGD
PMID:19212187 PMID:19212187
RGD:7364958 , RGD:7364958
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Ager
advanced glycosylation end product-specific receptor
IEP
mRNA:increased expression:liver
RGD
PMID:21431875
RGD:10402078
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Aldh2
aldehyde dehydrogenase 2 family member
treatment
ISO IEP
protein:altered expression:liver (mouse) protein:altered expression:liver (rat)
RGD
PMID:30671488 PMID:29589772
RGD:15036807 , RGD:14975297
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Atf6
activating transcription factor 6
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atg13
autophagy related 13
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
G
Atg16l1
autophagy related 16-like 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 9:88,420,737...88,457,530
Ensembl chr 9:88,422,038...88,457,529
G
Atg4d
autophagy related 4D, cysteine peptidase
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 8:19,807,733...19,817,321
Ensembl chr 8:19,807,766...19,817,321
G
Atg7
autophagy related 7
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
G
Bad
BCL2-associated agonist of cell death
treatment
IEP
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22647552 PMID:22847887
RGD:10053673 , RGD:10053710
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment ameliorates
IEP ISO
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22647552 PMID:22847887 PMID:21092002 PMID:34144219
RGD:10053673 , RGD:10053710 , RGD:5134995 , RGD:329812011
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment ameliorates
IDA IEP ISO
associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22847887 PMID:21092002 PMID:34144219
RGD:10053710 , RGD:5134995 , RGD:329812011
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
treatment
IEP
associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22847887
RGD:10053710
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Becn1
beclin 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
C3
complement C3
treatment
IEP
RGD
PMID:19854450
RGD:11040888
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Casp12
caspase 12
treatment
IEP
RGD
PMID:29428101
RGD:13782166
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
treatment
IEP ISO
RGD
PMID:23423194 PMID:15300206
RGD:8661760 , RGD:14695087
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment ameliorates
IEP ISO
RGD
PMID:23364428 PMID:34144219
RGD:13782358 , RGD:329812011
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
severity treatment ameliorates
IEP ISO
mRNA, protein:increased expression:liver, serum (rat)
RGD
PMID:9500701 PMID:27229110 PMID:10630515 PMID:34400126
RGD:8549627 , RGD:14995460 , RGD:14995929 , RGD:329902072
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
treatment severity
ISO
RGD
PMID:28623253 PMID:28623253
RGD:14995305 , RGD:14995305
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccn1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccr1
C-C motif chemokine receptor 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 8:123,556,286...123,561,841
G
Ccr2
C-C motif chemokine receptor 2
severity
ISO
RGD
PMID:27229110
RGD:14995460
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cd14
CD14 molecule
IDA
RGD
PMID:22564590
RGD:7183676
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd40
CD40 molecule
treatment
IMP
RGD
PMID:14741776
RGD:8547795
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cfh
complement factor H
treatment
IEP ISO
mRNA,protein:decreased expression:liver,plasma:
RGD
PMID:19212187 PMID:19212187
RGD:7364958 , RGD:7364958
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Cs
citrate synthase
IDA
RGD
PMID:25416448
RGD:13504849
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Cst3
cystatin C
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Cxcl1
C-X-C motif chemokine ligand 1
treatment ameliorates
IDA ISO
RGD
PMID:21092002 PMID:34400126
RGD:5134995 , RGD:329902072
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
treatment ameliorates
ISO
RGD
PMID:18041715 PMID:34400126
RGD:27095942 , RGD:329902072
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcl9
C-X-C motif chemokine ligand 9
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
mRNA:decreased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Ddit3
DNA-damage inducible transcript 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Elane
elastase, neutrophil expressed
IMP
RGD
PMID:10588515
RGD:10450560
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:25769561
RGD:15090809
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Epor
erythropoietin receptor
IEP
protein:increased phosphorylation:liver:
RGD
PMID:25769561
RGD:15090809
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
G
F3
coagulation factor III, tissue factor
treatment
IMP
RGD
PMID:11750579
RGD:11341708
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fadd
Fas associated via death domain
treatment
IEP
RGD
PMID:23423194
RGD:8661760
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
treatment
IMP IEP
protein:increased expression:liver
RGD
PMID:17235585 PMID:16222447 PMID:18561025
RGD:2290283 , RGD:1600351 , RGD:14700680
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IMP
RGD
PMID:18561025
RGD:14700680
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fga
fibrinogen alpha chain
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:23503399
RGD:9685021
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fn1
fibronectin 1
IDA
RGD
PMID:12651615
RGD:7205470
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Gpt
glutamic--pyruvic transaminase
treatment
IEP
RGD
PMID:22564598 PMID:13678701
RGD:329970282 , RGD:329970285
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
associated with nonalcoholic fatty liver disease
RGD
PMID:28807209
RGD:13792730
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gstm1
glutathione S-transferase mu 1
IEP
mRNA:decreased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
H2ax
H2A.X variant histone
treatment
IEP
RGD
PMID:23792534
RGD:8693718
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hmgb1
high mobility group box 1
treatment
IMP IEP
mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm protein:increased oxidation:liver
RGD
PMID:24578610 PMID:21431875 PMID:22514737
RGD:10402068 , RGD:10402078 , RGD:10402175
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IEP
RGD
PMID:20446775
RGD:10755725
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
treatment
IEP
RGD
PMID:17187421 PMID:21699906
RGD:1626366 , RGD:11041815
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Icam1
intercellular adhesion molecule 1
treatment
IMP IEP
associated with Intestinal Reperfusion Injury;protein:increased expression:liver
RGD
PMID:7884306 PMID:8780571
RGD:11520784 , RGD:14402044
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
RGD
PMID:28938192
RGD:14985248
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
IDA
RGD
PMID:22381173
RGD:12791280
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:21911118
RGD:7364839
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
treatment
IEP ISO
RGD
PMID:25919765 PMID:14999688
RGD:14696667 , RGD:14696668
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
IEP
mRNA,protein:increased expression:liver
RGD
PMID:25919765
RGD:14696667
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il1a
interleukin 1 alpha
treatment
IEP IDA
mRNA:increased expression:lung protein:increased expression:serum
RGD
PMID:19595018 PMID:19283466 PMID:9840148
RGD:2314952 , RGD:6907377 , RGD:11059517
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
treatment ameliorates
IDA ISO
associated with Cholestasis
RGD
PMID:21468628 PMID:32155285 PMID:34400126
RGD:7175318 , RGD:155260323 , RGD:329902072
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO IMP
rat model treated with human protein
RGD
PMID:9000676 PMID:12451245
RGD:6909138 , RGD:8551710
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
treatment ameliorates
IDA ISO
RGD
PMID:24752458 PMID:32155285 PMID:34144219 PMID:34400126
RGD:11062134 , RGD:155260323 , RGD:329812011 , RGD:329902072
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf8
interferon regulatory factor 8
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
Itgam
integrin subunit alpha M
treatment exacerbates
IMP IEP
protein:increased expression:neutrophil (rat)
RGD
PMID:8387952 PMID:11447039
RGD:329901847 , RGD:329901849
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Jak2
Janus kinase 2
treatment
IDA
RGD
PMID:22288937
RGD:10403073
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Lamp2
lysosomal-associated membrane protein 2
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
G
Lbp
lipopolysaccharide binding protein
IEP
mRNA, protein:increased expression:liver
RGD
PMID:12134092
RGD:9685192
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ameliorates exacerbates
ISO
protein:increased phosphorylation:liver (mouse)
RGD
PMID:30076625 PMID:30622220
RGD:155804280 , RGD:155882441
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Mapk8
mitogen-activated protein kinase 8
IEP
protein:increased activity:liver:
RGD
PMID:11679968
RGD:10412680
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mfn2
mitofusin 2
treatment
IEP
mRNA, protein:decreased expression:liver (rat)
RGD
PMID:27363631 PMID:24898700
RGD:12910833 , RGD:13204829
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mir145
microRNA 145
IEP
mRNA:decreased expression:small intestine (rat)
RGD
PMID:23166305
RGD:155230822
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
G
Mir155
microRNA 155
ISO
RGD
PMID:28640790
RGD:21079442
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
IEP
RNA:increased expression:liver
RGD
PMID:29187695
RGD:41410824
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir210
microRNA 210
treatment
ISO
RGD
PMID:32155285
RGD:155260323
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
G
Mir223
microRNA 223
ISO
RNA:increased expression:liver RNA:increased expression:serum,liver
RGD
PMID:19104939 PMID:28646120
RGD:13831297 , RGD:21408574
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mir34a
microRNA 34a
IEP
miRNA:increased expression:liver
RGD
PMID:28963950
RGD:14695005
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
G
Mmp15
matrix metallopeptidase 15
IEP
mRNA:increased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
G
Mmp9
matrix metallopeptidase 9
treatment
IEP
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver
RGD
PMID:17255325
RGD:8547976
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Muc1
mucin 1, cell surface associated
IEP
mRNA, protein:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Muc3
mucin 3
IEP
mRNA, protein:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr12:19,527,251...19,536,924
Ensembl chr12:19,527,321...19,538,522
G
Muc4
mucin 4, cell surface associated
IEP
mRNA:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr11:68,008,245...68,053,242
G
Nfatc1
nuclear factor of activated T-cells 1
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:36092961
RGD:268357360
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22288937 PMID:31952110
RGD:10403073 , RGD:21201304
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos3
nitric oxide synthase 3
treatment
IEP
RGD
PMID:28966130
RGD:13450941
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Pf4
platelet factor 4
exacerbates
ISO
RGD
PMID:25440775
RGD:329901829
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:12605111 PMID:18507760
RGD:11100021 , RGD:11100046
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Rab10
RAB10, member RAS oncogene family
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 6:26,267,081...26,319,739
Ensembl chr 6:26,266,859...26,320,193
G
Rab8b
RAB8B, member RAS oncogene family
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 8:67,458,921...67,536,466
Ensembl chr 8:67,458,923...67,536,384
G
Selplg
selectin P ligand
ameliorates
IMP
RGD
PMID:16365457
RGD:401717523
NCBI chr12:42,796,690...42,809,908
Ensembl chr12:42,796,580...42,812,585
G
Serpinc1
serpin family C member 1
treatment
IEP ISO
RGD
PMID:24726586 PMID:8589354
RGD:10450597 , RGD:11038771
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Serpine1
serpin family E member 1
IEP
protein:increased activity:plasma (rat)
RGD
PMID:12353078
RGD:8547901
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serping1
serpin family G member 1
treatment
ISO
RGD
PMID:16367929
RGD:1580273
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sirt1
sirtuin 1
treatment
IEP
RGD
PMID:24557422
RGD:9497542
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slpi
secretory leukocyte peptidase inhibitor
IEP
RGD
PMID:19595018
RGD:2314952
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Sod1
superoxide dismutase 1
treatment
ISO
human gene in a rat model
RGD
PMID:16555330 PMID:11779401
RGD:8655889 , RGD:1581095
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod3
superoxide dismutase 3
treatment
ISO
human gene in a rat model
RGD
PMID:11779401
RGD:1581095
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Tert
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:19545665
RGD:11038676
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tfpi
tissue factor pathway inhibitor
ISO
RGD
PMID:9921794
RGD:11062061
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tlr2
toll-like receptor 2
treatment
ISO IEP
RGD
PMID:16038046 PMID:25769561
RGD:15090805 , RGD:15090809
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment severity
IEP ISO
mRNA:increased expression:liver protein:increased expression:membrane raft:
RGD
PMID:21431875 PMID:27064547 PMID:23395256 PMID:22797797 PMID:21693218
RGD:10402078 , RGD:14697698 , RGD:14697699 , RGD:14697702 , RGD:5685379
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
treatment
IEP IMP ISO
protein:increased expression:serum (rat)
RGD
PMID:24726586 PMID:17164725 PMID:15457564 PMID:10454827 PMID:21125813 PMID:11129814 PMID:19357028 PMID:11592783 PMID:32155285 More...
RGD:10450597 , RGD:14696803 , RGD:14985257 , RGD:14985258 , RGD:14995447 , RGD:14995473 , RGD:15039406 , RGD:2325259 , RGD:155260323
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP
protein:increased localization:mitochondrion
RGD
PMID:23423194
RGD:8661760
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tradd
TNFRSF1A-associated via death domain
treatment
IEP
RGD
PMID:23423194
RGD:8661760
NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
G
Ucp2
uncoupling protein 2
IEP
mRNA:increased expression:liver
RGD
PMID:22195248
RGD:7175309
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Vegfa
vascular endothelial growth factor A
IEP
RGD
PMID:26451003
RGD:15036791
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
treatment
IEP
RGD
PMID:24768926
RGD:13209011
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all